Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • The RBA eases monetary policy, but still sees a cloudy outlook
    • News

    The RBA eases monetary policy, but still sees a cloudy outlook

    RBA benchmark rate is cut by 25 basis points at the May Board meeting As was widely expected by all and sundry, the RBA’s benchmark interest rate was reduced by 25 basis points to 3.85% at the 19-20 May RBA Board meeting. Policy makers even briefly considered whether a 50 basis point cut was an

    Read More
    Public
  • Saunders Secures $27M Contract to Boost Gold Production at Kalgoorlie
    • News

    Saunders Secures $27M Contract to Boost Gold Production at Kalgoorlie

    Expanding Western Australia’s Gold Processing Capacity The Australian resources sector has gained fresh momentum as Saunders International Limited (ASX:SND) announced a significant contract win. The $27 million agreement, awarded by Primero, marks Saunders’ continued involvement in enhancing operations at Kalgoorlie Consolidated Gold Mines (KCGM), one of Western Australia’s iconic mining sites. This contract will see

    Read More
    Public
  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    • News

    4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path

    A growing U.S. demand for faster, AI-powered tools in cardiopulmonary care is opening up substantial commercial opportunities for Australian medtech company 4DMedical (ASX:4DX). The Melbourne-based imaging innovator has secured a significant contract with Intermountain Health—one of the United States’ largest and most respected health systems—for the rollout of its newly FDA-cleared Pulmonary Hypertension Analysis (PHA™)

    Read More
    Public
  • Race Oncology Doses First Patient in RC220 Trial, Advancing Tumour Program
    • News

    Race Oncology Doses First Patient in RC220 Trial, Advancing Tumour Program

    Race Oncology (ASX:RAC) has taken a step towards the development of a new cancer-fighting drug therapy, dosing the first patient in its Phase 1 trial of RC220, a reformulated version of bisantrene, aimed at treating advanced solid tumours. The early-stage trial marks a key milestone for Australia’s biotech sector and positions Race Oncology at the forefront

    Read More
    Public
  • March 2025 quarter CPI above expectations – but RBA cut still likely
    • News

    March 2025 quarter CPI above expectations – but RBA cut still likely

    The March 2025 quarter CPI data released today were a touch above market expectations. The headline CPI rose by 0.9% over the quarter, well up on the slight 0.2% increase reported in the prior quarter. This delivered an annual CPI increase in the March 2025 quarter of 2.4%, which matched that reported in the prior

    Read More
    Public
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians
    • News

    Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians

    Just 12 months after launching their refurbished tech division, eCommerce company Harris Technology (ASX: HT8) is set to consolidate its position as a leading seller of refurbished tech products in Australia by expanding into new product categories.  The expansion opportunity comes after Harris Technology caught the attention of Taiwanese tech giant FSP Technology Inc which

    Read More
    Public
  • «
  • ‹
  • 13
  • 14
  • 15
  • 16
  • 17
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.